Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cell adhesion inhibitors disclosed by Nippon Shinyaku

March 12, 1997

Gelatinase inhibitors prepared by Ono

March 11, 1997

MMP inhibitors from Ono

March 10, 1997

U.S. patent covers Immunex's TNFR

March 7, 1997

IVAX receives approval for generic NSAID

March 6, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Protein kinase inhibitors reported by Roche

March 5, 1997

Teva's Tolmetin approved

March 4, 1997

Celgene receives patent for selective cytokine-inhibitory drugs

March 4, 1997

Faulding receives approval for etodolac tablets

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...